Dataset: 9.3K articles from Wikipedia (CC BY-SA).
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Highlight for Query ‹Mycoplasma hominis infection medication

Microsporidiosis

Abstract

Microsporidiosis is an opportunistic intestinal infection that causes diarrhea and wasting in immunocompromised individuals (HIV, for example). It results from different species of microsporidia, a group of microbial (unicellular) fungi.

In HIV infected individuals, microsporidiosis generally occurs when CD4+ T cell counts fall below 150.

Classification

Although it is classified as a protozoal disease in ICD-10, their phylogenetic placement has been resolved to be within the Fungi, and some sources classify microsporidiosis as a mycosis, however, they are highly divergent and rapidly evolving.

Causative agents

At least 14 microsporidian species have been recognized as human pathogens, spread across eight genera:

- "Brachiola"

- "B. algerae", "B. connori", "B. vesicularum"

- "Encephalitozoon"

- "E. cuniculi", "E. hellem", "E. intestinalis"

- Enterocytozoon

- "E. bieneusi"

- "Microsporidium"

- "M. ceylonensis", "M. africanum"

- "Nosema"

- "N. ocularum"

- "Pleistophora sp."

- "Trachipleistophora"

- "T. hominis", "T. anthropophthera"

- "Vittaforma"

- "V. corneae."

The primary causes are "Enterocytozoon bieneusi" and "Encephalitozoon intestinalis".

Life cycle

"(Coded to at right)."

1. The infective form of microsporidia is the resistant spore and it can survive for an extended period of time in the environment.

2. The spore extrudes its polar tubule and infects the host cell.

3. The spore injects the infective sporoplasm into the eukaryotic host cell through the polar tubule.

4. Inside the cell, the sporoplasm undergoes extensive multiplication either by merogony (binary fission) or schizogony (multiple fission).

5. This development can occur either in direct contact with the host cell cytoplasm ("E. bieneusi") or inside a vacuole called a parasitophorous vacuole ("E. intestinalis"). Either free in the cytoplasm or inside a parasitophorous vacuole, microsporidia develop by sporogony to mature spores.

6. During sporogony, a thick wall is formed around the spore, which provides resistance to adverse environmental conditions. When the spores increase in number and completely fill the host cell cytoplasm, the cell membrane is disrupted and releases the spores to the surroundings.

7. These free mature spores can infect new cells thus continuing the cycle.

Treatment

Fumagillin has been used in the treatment.

Another agent used is albendazole.